Author

Marco Campisi

Dana-Farber Cancer InstituteORCID 0000-0002-9288-5285Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

David Allen BarbieiD· 2 shared Alaa Kassim AliiD· 1 shared Alice CheniD· 1 shared Andreia MaiaiD· 1 shared Andrew A. LaneiD· 1 shared Andrew J. AguirreiD· 1 shared Anna Clara BaderiD· 1 shared Ashley HuiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

David Allen BarbieORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tumor-tropic E. coli engineered as living T and NK cell engagers

Shaobo Yang, Anna Clara Bader, Stephanie Sendker, Ashley Hu, Daniel Chuyang Chen, Hetal Nath, Alice Chen, Eden Bobilev, Michal Sheffer, Veronica W. Hui, Tereza Kochs, Andreia Maia, Jiting Tang, Fuguo Liu, Xingyu Deng, , Rizwan Romee

This paper develops LIME, a bacterial platform that engagers T and NK cells to target tumors, showing enhanced cytotoxicity and immune response in preclinical models.

bioRxiv · Aug 20, 2026 · PreprintBioengineering

miR126-mediated impaired vascular integrity in Rett syndrome

Tatsuya Osaki, Zhengpeng Wan, Koji Haratani, Ylliah Jin, Marco Campisi, David Allen Barbie, Roger Dale Kamm, Mriganka Sur

This study investigates vascular impairment in Rett syndrome by analyzing patient-derived endothelial cells and identifies miR126-3p as a mediator of vascular dysfunction.

Molecular Psychiatry · Feb 18, 2026Peer-reviewedCell Biology